Dr. Andrawis is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
5631 Burke Centre Pkwy
Suite A
Burke, VA 22015Phone+1 703-250-5171Fax+1 703-250-5170- Is this information wrong?
Education & Training
- Brown UniversityResidency, Internal Medicine, 1991 - 1994
- Ain Shams University Faculty of MedicineClass of 1976
Certifications & Licensure
- DC State Medical License 1994 - Present
- VA State Medical License 1995 - 2024
Awards, Honors, & Recognition
- Top Doctors:Washington DC Area Castle Connolly, 2012
- Top Doctors:Washington-Baltimore Castle Connolly, 2012
- CMS Meaningful Use Stage 1 Certification Practice Fusion EHR, Practice Fusion, Inc., 2011
Clinical Trials
- A Study to Evaluate the Efficacy of MEDI8968 in Chronic Obstructive Pulmonary Disease Start of enrollment: 2011 Nov 01
- Study to Evaluate the Effects of BMS-813160 on Protein Loss in the Urine of Subjects With Type 2 Diabetes and Diabetic Kidney Disease Start of enrollment: 2013 Mar 18
- Multicenter Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women With Diabetic Gastroparesis Start of enrollment: 2014 Mar 27
- Join now to see all
Publications & Presentations
PubMed
- Author Correction: The FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial.Bays, H., Miller, M., Cain, J., Wasilewska, K., Feng, S., Sterling, L., Tseng, L., Hartsfield, C., Agollah, G., Mansbach, H., Kastelein, J., , Bhatt, D., Andrawis, N.,...> ;Nature Medicine. 2024 Mar 4
- 13 citationsThe FGF21 analog pegozafermin in severe hypertriglyceridemia: a randomized phase 2 trial.Deepak L Bhatt, Harold E Bays, Michael Miller, James E Cain 3rd, Katarzyna Wasilewska, Nabil S Andrawis, Teresa Parli, Shibao Feng, Lulu Sterling, Leo Tseng, Cynthia L...> ;Nature Medicine. 2023 Jul 1
- 7 citationsTolerability, safety and pharmacodynamics of oral, small-molecule glucagon-like peptide-1 receptor agonist danuglipron for type 2 diabetes: A 12-week, randomized, plac...Aditi R Saxena, Juan P Frias, Donal N Gorman, Rene N Lopez, Nabil Andrawis, Nikolaos Tsamandouras, Morris J Birnbaum> ;Diabetes, Obesity & Metabolism. 2023 Oct 1
- Join now to see all
Professional Memberships
- Member
Other Languages
- Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: